Name
Ascentage Pharma
Company Description
Ascentage Pharma Group is a global biopharmaceutical company engaged in developing novel therapies for various hematological disorders. The company has multiple on-going across clinical trials in all phases that involve the use of novel investigational agents such as third-generation tyrosine kinase inhibitors olverembatinib, Bcl-2 inhibitor lisaftoclax, MDM2-p53 inhibitor alrizomadlin, dual Bcl-2/Bcl-xL inhibitor pelcitoclax, and EED inhibitor APG-5918 to address unmet medical needs.
Website
https://www.ascentage.com/
Product Categories (5)
Pharmaceuticals, Malignant, Clinical Research, Research Grants
Address
700 King Farm Blvd., Suite 510
Rockville, MD 92009
United States